Oxy Watchdog

Keeping An Eye On OxyContin

FDA OKs less-abusable Oxy

Posted by Oxy Watchdog on April 6, 2010

The U.S. Food and Drug Administration has approved a new formulation of controlled-release OxyContin that is intended to make the powerful painkiller harder to abuse. The new formulation will most likely result in less abuse by inhaling or injection, but can still be abused or misused by ingesting larger doses than are recommended, the agency said.

Purdue Pharma LP, OxyContin’s maker, admits that “there is no evidence that the reformulation of OxyContin is less subject to misuse, abuse, diversion, overdose or addiction.”

Advertisements

3 Responses to “FDA OKs less-abusable Oxy”

  1. […] the U.S. manufacturer of OxyContin, Purdue Pharma LP, which recently submitted a new patent for the reformulated version of the painkiller. The new patent ensures other companies will not be able to create generic forms of oxycodone, […]

  2. […] To read more about the new version of slow-release OxyContin, go here. […]

  3. […] Read about Purdue’s less-abusable version of OxyContin here. […]

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s

 
%d bloggers like this: